Roche Q1 sales down on forex effects
23/04/2026 06:01
April 23 (Reuters) - Swiss drugmaker Roche ROPC.S said on Thursday that its first-quarter sales declined because of negative foreign exchange effects but rose at constant exchange rates. Quarterly group revenues came in at 14.72 billion Swiss francs ($18.74 billion), in line with average analyst expectations of about 14.73 billion francs cited by Visible Alpha. ($1 = 0.7854 Swiss francs) (Reporting by Marleen Kaesebier Editing by Ludwig Burger) ((marleen.kaesebier@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza